Literature DB >> 7066264

Sickle cell retinopathy in young children in Jamaica.

J F Talbot, A C Bird, G R Serjeant, R J Hayes.   

Abstract

Ophthalmological examinations were performed on 59 of the 74 (80%) children with homozygous sickle cell (SS) disease and on 37 of the 54 (69%) children with sickle cell-haemoglobin C (SC) disease, aged 5-7.5 years, within the cohort study of sickle cell disease. Arteriolar sheathing was the commonest retinal vessel abnormality, occurring in 30/59 (51%) SS children and in 11/37 (30%) SC children. Peripheral arteriolar closure was observed in 14 (24%) SS children and in 6 (16%) SC children. Arteriovenous anastomoses were seen in 3 children, but proliferative retinopathy was not identified. Capillary changes often occurred in patients without confluent closure, suggesting that complex remodelling of the capillary bed may precede retinal non-perfusion. Discrete retinal patches similar to schisis cavities resulting intraretinal haemorrhages were found in 22 (37%) SS children and in 9 (24%) SC children, but haemorrhages were observed in only 2 patients (1 SS, 1 SC). Vitreous opacities were common and were generally associated with retinal vessel disease. Retinal changes were consistently more common in children with SS disease, though the differences failed to reach statistical significance. The prevalence of peripheral vascular closure and retinal patches showed a significant upward trend with age. These observations contrast with the greater prevalence of proliferative retinopathy characterising SC disease in adults.

Entities:  

Mesh:

Year:  1982        PMID: 7066264      PMCID: PMC1039742          DOI: 10.1136/bjo.66.3.149

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Evolution of the retinal black sunburst in sickling haemoglobinopathies.

Authors:  G Asdourian; K C Nagpal; M Goldbaum; D Patrianakos; M F Goldberg; M Rabb
Journal:  Br J Ophthalmol       Date:  1975-12       Impact factor: 4.638

2.  Spontaneous remodeling of the peripheral retinal vasculature in sickling disorders.

Authors:  S O Galinos; G K Asdourian; M B Woolf; T S Stevens; C B Lee; M F Goldberg; J C Chow; B J Busse
Journal:  Am J Ophthalmol       Date:  1975-05       Impact factor: 5.258

3.  Ocular findings in children with sickle cell haemoglobin C disease in Jamaica.

Authors:  P I Condon; R Gray; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1974-07       Impact factor: 4.638

4.  Screening cord bloods for detection of sickle cell disease in Jamaica.

Authors:  B E Serjeant; M Forbes; L L Williams; G R Serjeant
Journal:  Clin Chem       Date:  1974-06       Impact factor: 8.327

5.  Ocular findings in hemoglobin SC disease in Jamaica.

Authors:  P I Condon; G R Serjeant
Journal:  Am J Ophthalmol       Date:  1972-11       Impact factor: 5.258

6.  Ocular findings in homozygous sickle cell anemia in Jamaica.

Authors:  P I Condon; G R Serjeant
Journal:  Am J Ophthalmol       Date:  1972-04       Impact factor: 5.258

7.  Classification and pathogenesis of proliferative sickle retinopathy.

Authors:  M F Goldberg
Journal:  Am J Ophthalmol       Date:  1971-03       Impact factor: 5.258

8.  Natural history of untreated proliferative sickle retinopathy.

Authors:  M F Goldberg
Journal:  Arch Ophthalmol       Date:  1971-04

9.  Sickle-cell hemoglobin and its relation to fundus abnormality.

Authors:  R B Welch; M F Goldberg
Journal:  Arch Ophthalmol       Date:  1966-03

10.  Retinal depression sign indicating a small retinal infarct.

Authors:  M H Goldbaum
Journal:  Am J Ophthalmol       Date:  1978-07       Impact factor: 5.258

View more
  11 in total

Review 1.  New Ways to Detect Pediatric Sickle Cell Retinopathy: A Comprehensive Review.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Royce W S Chen
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

2.  New classification of peripheral retinal vascular changes in sickle cell disease.

Authors:  A D Penman; J F Talbot; E L Chuang; P Thomas; G R Serjeant; A C Bird
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

3.  Retinal changes in sickle cell/hereditary persistence of fetal haemoglobin syndrome.

Authors:  J F Talbot; A C Bird; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

4.  Ocular findings in sickle cell patients on Curaçao.

Authors:  J C van Meurs
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

5.  Optical Coherence Tomography Angiography and Ultra-widefield Fluorescein Angiography for Early Detection of Adolescent Sickle Retinopathy.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Margaret T Lee; Jonathan S Chang; Maureen Licursi; Courtney Briamonte; Elana Smilow; Royce W S Chen
Journal:  Am J Ophthalmol       Date:  2017-08-30       Impact factor: 5.258

6.  Blood rheology and proliferative retinopathy in sickle cell-haemoglobin C disease.

Authors:  B E Serjeant; K P Mason; P I Condon; R J Hayes; M W Kenny; J Stuart; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

7.  Sickle cell retinopathy in Jamaican children: a search for prognostic factors.

Authors:  J F Talbot; A C Bird; L M Rabb; G H Maude; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

8.  Peripheral retinal vasculature in normal Jamaican children.

Authors:  A Penman; J F Talbot; E L Chuang; A C Bird; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

Review 9.  The past, present and future management of sickle cell retinopathy within an African context.

Authors:  Kwesi Nyan Amissah-Arthur; Evelyn Mensah
Journal:  Eye (Lond)       Date:  2018-07-10       Impact factor: 3.775

10.  A comprehensive texture segmentation framework for segmentation of capillary non-perfusion regions in fundus fluorescein angiograms.

Authors:  Yalin Zheng; Man Ting Kwong; Ian J C Maccormick; Nicholas A V Beare; Simon P Harding
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.